dc.contributor.author | Mohseni, F | |
dc.contributor.author | Farajnia, S | |
dc.contributor.author | Farhangi, MA | |
dc.contributor.author | Khoshbaten, M | |
dc.contributor.author | Jafarabadi, M-A | |
dc.date.accessioned | 2018-08-26T08:36:31Z | |
dc.date.available | 2018-08-26T08:36:31Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52753 | |
dc.description.abstract | Objective: To investigate the association of uncoupling protein-2 (UCP2) -866G>A gene polymorphism (rs659366) with nonalcoholic fatty liver disease (NAFLD). Methods: We performed a case-control study with a cohort of 75 patients with NAFLD (of Iranian ethnicity) and 76 healthy individuals of Iranian ethnicity. The UCP2 -866G>A polymorphism (rs659366) was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: Patients with AA and AG genotypes were 71% and 68%, respectively, more likely to have NAFLD, compared with individuals with the GG genotype (reference group). In subjects with a GG genotype, serum triglyceride (TG) concentration was significantly higher in patients with NAFLD (P=.04). Serum alanine aminotransferase (ALT) concentrations in all 3 genotypes and serum aspartate aminotransferase (AST) concentrations in AG and GG genotypes of UCP2 gene polymorphism were significantly higher in patients (P <.05). Conclusion: Our results revealed a modest modifier effect of -866G>A UCP2 polymorphism in patients with NAFLD. آ©American Society for Clinical Pathology, 2016. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Lab Medicine | |
dc.subject | alanine aminotransferase | |
dc.subject | aspartate aminotransferase | |
dc.subject | genomic DNA | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | low density lipoprotein | |
dc.subject | triacylglycerol | |
dc.subject | uncoupling protein 2 | |
dc.subject | UCP2 protein, human | |
dc.subject | uncoupling protein 2 | |
dc.subject | adult | |
dc.subject | alanine aminotransferase blood level | |
dc.subject | alcohol consumption | |
dc.subject | Article | |
dc.subject | aspartate aminotransferase blood level | |
dc.subject | basal metabolic rate | |
dc.subject | body composition | |
dc.subject | body mass | |
dc.subject | case control study | |
dc.subject | cholesterol blood level | |
dc.subject | controlled study | |
dc.subject | DNA polymorphism | |
dc.subject | female | |
dc.subject | genotype | |
dc.subject | hip circumference | |
dc.subject | human | |
dc.subject | Iran | |
dc.subject | Iranian people | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | nonalcoholic fatty liver | |
dc.subject | polymerase chain reaction | |
dc.subject | restriction fragment length polymorphism | |
dc.subject | triacylglycerol blood level | |
dc.subject | waist circumference | |
dc.subject | waist hip ratio | |
dc.subject | Asian continental ancestry group | |
dc.subject | genetics | |
dc.subject | middle aged | |
dc.subject | nonalcoholic fatty liver | |
dc.subject | single nucleotide polymorphism | |
dc.subject | Adult | |
dc.subject | Asian Continental Ancestry Group | |
dc.subject | Case-Control Studies | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Iran | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Non-alcoholic Fatty Liver Disease | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Uncoupling Protein 2 | |
dc.title | Association of UCP2 -866G>A polymorphism with nonalcoholic fatty liver disease in patients from North-West of Iran | |
dc.type | Article | |
dc.citation.volume | 48 | |
dc.citation.issue | 1 | |
dc.citation.spage | 65 | |
dc.citation.epage | 72 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1093/labmed/lmw052 | |